# Nature-Style Re-Review After Manuscript Fixes: CONFIRM

Date: 2026-06-20

Input scope: current `paper/main.tex`, manuscript sections in `paper/sec/`, current LaTeX tables under `paper/figures/`, `RESULTS_MANIFEST_20260620.md`, `EXTERNAL_BENCHMARK_PREREG.md`, `EXTERNAL_BENCHMARK_RESULTS.md`, and external result artifacts in `review-stage/external-nacc/` and `review-stage/external-cnp/`.

Assessment boundary: This is a reviewer-style re-review against the previous Nature-style concerns. It is not an editorial decision, not a citation audit, and not a full reproducibility rerun. I inspected local text/artifacts only.

## Resolution Audit

Overall: the current version is substantially stronger than the prior version. The paper now more clearly frames CONFIRM as claim governance rather than raw discovery capability; it adds a benchmark map, stronger gate ablations, a per-claim appendix, a hardened power-gate description, and explicit reporting of the ds000030/CNP external non-confirmation. Several previous concerns are genuinely improved. The remaining problems are now mostly consistency/provenance problems rather than missing-concept problems.

### Previously Raised Concerns That Are Largely Resolved

1. Stress-suite overclaiming: improved. The abstract, E4, and limitations now state that the 177-claim result is a synthetic, gate-targeted internal stress-test characteristic, not a real-world false-confirmation rate.

2. Power-gate vulnerability: mostly resolved in method and manifest. The method now says power is judged against a pre-declared minimal effect/reference value and never against the observed effect. The manifest states the power code was changed and rerun.

3. Weak baselines: materially improved. The new ablation table compares significance plus FDR, replication, confound, confound plus replication, and leave-one-gate-out variants. This directly addresses the prior request for simpler governance baselines.

4. Benchmark opacity: improved. The new benchmark map explains what each evidence stratum licenses, and the appendix now gives a per-claim main-benchmark verdict table.

5. External failure hiding: improved. The ds000030/CNP external cohort is now reported in the manuscript instead of omitted.

6. Confound-completeness overclaiming: mostly resolved. The method now explicitly calls it a prespecified coverage check over a fixed structural-confound list, not a guarantee of complete confounding control.

7. Low coverage/conservatism: resolved in framing. The discussion now treats conservatism as the intended governance tradeoff rather than a hidden cost.

### Concerns Only Partially Resolved

1. Provenance and preregistration: partially resolved. `RESULTS_MANIFEST_20260620.md` is a real improvement because it maps manuscript numbers to artifacts and explicitly says the external runs are frozen-configuration evaluations, not formal preregistrations. However, `EXTERNAL_BENCHMARK_PREREG.md` still says "DRAFT preregistration (not yet frozen)", and the conclusion still says the benchmark is released to support a "preregistered, external evaluation of real-world faithfulness." The paper should align everywhere with the manifest: frozen-configuration, hash-recorded, not formal preregistration.

2. External validation: partially resolved. NACC is now framed more carefully, and CNP is reported. But the manuscript still leans toward "external validation" language while the external positives are dominated by AD/MCI in NACC, and ds000030 has 0/14 positive recovery.

3. Multi-LLM robustness: partially resolved. The manuscript calls it a six-model probe in the abstract and describes the small nine-claim subset in E3, which is better. The phrase "verdicts are stable across six LLMs" remains a bit too strong unless consistently qualified as a small probe.

4. Per-claim provenance: partially resolved. The appendix adds per-claim verdicts for the main benchmark, but it does not include full label source provenance, external claims, stress-suite claims, or artifact hashes. The manifest covers hashes at the artifact level; a reviewer may still ask for claim-level label provenance.

### Concerns Not Yet Resolved

1. Stale stress-suite numbers remain in the conclusion. The abstract/E4/limitations now report `0/177` and a 2.1% upper bound, but `paper/sec/07_conclusion.tex` still says "one false confirmation" and "3.1%". This is a direct internal contradiction.

2. The ds000030/CNP interpretation conflicts with the artifact. The manuscript says ds000030 is "underpowered" and that "the power and replication gates withhold the claims." The CNP artifact shows `under_powered: false` for all shown claims, achieved power around 0.85 to 0.92, and final labels `fragile`. The local summary also reports 0 underpowered claims by label group. Either the artifact/power calculation is wrong, or the manuscript explanation is wrong.

3. The external success criterion remains failed in the artifacts. NACC has an upper 95% null-control bound of 12.3%, above the 10% target; CNP has 0/14 positive recovery and also fails the TPR bar. Combining NACC and ds000030 controls gives 0/44, but this should not be written as if the external benchmark met the original preregistered bar, especially because the psychiatric positives were not recovered.

4. The title still overreaches. "Trustworthy Agentic Neuroimaging Discovery" remains broader than the evidence. The paper's strongest claim is "statistical claim governance" or "false-confirmation governance", not trustworthy discovery.

5. The power-gate implementation may require further explanation. The current CNP artifact suggests the power gate can pass designs with roughly 20 to 25 cases per split under the default/reference calculation. If the authors want to argue these claims are underpowered, the manuscript must define a group-specific or literature-effect power calculation and rerun the artifact accordingly.

## Reviewer 1

### Overall Assessment

The revised manuscript makes meaningful technical progress. The paper now has a much clearer governance architecture, a stronger ablation baseline, explicit stress-test boundaries, and a result manifest tying many numbers to artifacts. These changes resolve several of the earlier technical-review objections.

The case is still not fully established because the current manuscript contains factual inconsistencies that a careful reviewer would catch quickly. The two most serious are the stale conclusion numbers and the ds000030/CNP underpowered explanation, which is not supported by the current CNP artifact. These are fixable, but they must be fixed before the paper can be considered internally reliable.

### Who Would Be Interested In The Results, And Why

Researchers building LLM scientific agents, neuroimaging-methods researchers, and statisticians interested in reproducible exploratory workflows would care. The work is most compelling for people who need an auditable layer between automated analysis execution and scientific prose.

### Major Strengths

1. The method now clearly separates LLM authority from statistical authority.

2. The power-gate vulnerability is acknowledged and the method now describes a pre-declared MDE/reference effect rather than observed-effect power.

3. The ablation table is a major improvement over a significance-only comparison.

4. The benchmark map is valuable because it prevents accidental pooling of internal, synthetic, agent, and external evidence.

5. The result manifest is a concrete step toward reproducibility.

6. Reporting ds000030/CNP is the right move, even though it weakens the broad external-validation story.

### Major Concerns

1. The conclusion contradicts the revised results. It still reports one false confirmation and a 3.1% upper bound, while the rest of the current manuscript and manifest report 0/177 and a 2.1% upper bound.

2. The ds000030 explanation is not artifact-grounded. The manuscript says the design is underpowered and that the power gate withholds claims, but the artifact reports `under_powered: false` and achieved power above 0.85 for the displayed CNP claims. The claims are withheld as fragile/non-replicated/multiverse failures, not as underpowered failures.

3. The preregistration/provenance wording is still inconsistent. The manifest says not to claim formal preregistration; the old preregistration file still says draft/not frozen; parts of the manuscript still gesture toward preregistered external evaluation.

4. External validation remains narrow. NACC is strong for AD/MCI structural effects but does not establish general neuroimaging external validity. ds000030 adds an important negative external result, but it does not strengthen positive transportability.

5. The main per-claim appendix is useful but still incomplete as provenance. It lists claims and gates, not the external label source or artifact identity for each claim.

### Technical Failings That Need To Be Addressed Before The Case Is Established

1. Make all stress-suite counts consistent: either `0/177` and 2.1% everywhere, or explain a different denominator/run.

2. Rewrite or rerun the ds000030 section. If the artifact is current, say the claims were not confirmed because they failed multiplicity/multiverse/replication despite the current power check passing. If the intended claim is underpowering, change the power calculation and regenerate the artifact.

3. Retire or update `EXTERNAL_BENCHMARK_PREREG.md`, or clearly mark it as superseded by the manifest. Do not let a reviewer see both "draft/not frozen" and "frozen/run once" as live claims.

4. Add a claim-level label-provenance table, including label source, label class, whether the claim was internal/synthetic/external, and artifact hash.

5. Clarify whether power is computed using total sample size, effective two-sample group size, minimum group size, or another quantity. The CNP interpretation depends on this.

### Assessment Against Nature-Style Criteria

Originality: Improved and credible as a claim-governance architecture. The strongest originality remains the contractual integration of LLM-drafted claims, code-only numbers, gate adjudication, and numeric authorization.

Scientific importance: Potentially important for scientific agents, but not yet established as outstanding broad scientific importance. The evidence supports safety/governance more than discovery.

Interdisciplinary readership: Improved. The problem framing is understandable beyond neuroimaging, but the empirical evidence is still field-specific.

Technical soundness: Better than before, but currently blocked by internal inconsistencies and the ds000030 artifact mismatch.

Readability for nonspecialists: Improved by the benchmark map and conceptual framing. Still dense, but less opaque than the prior version.

### Recommendation Posture

Promising after revision, but technical consistency must be fixed before the current version is reviewer-ready.

## Reviewer 2

### Overall Assessment

The revised version better understands its own contribution. It now presents CONFIRM as a conservative claim-governance layer rather than an all-purpose discovery agent. This is the right direction and makes the paper more defensible.

The remaining issue is significance calibration. Even after the fixes, the manuscript sometimes sells a broader result than the evidence supports. The title, the external-validation language, and the conclusion's "real-world faithfulness" phrase remain more ambitious than the demonstrated result.

### Who Would Be Interested In The Results, And Why

The paper would interest AI-for-science researchers, neuroimaging reproducibility researchers, and builders of automated analysis systems. The broadest readership hook is not a neuroimaging biomarker result; it is the claim that agentic scientific systems need enforceable statistical contracts before they are allowed to write results.

### Major Strengths

1. The paper's conceptual contribution is now sharper: faithfulness, not capability.

2. The related-work framing is improved because it distinguishes execution integrity from statistical admissibility.

3. The new ablations make the contribution less dependent on a weak significance-only baseline.

4. The external section is more honest because it reports both NACC success and ds000030 non-confirmation.

5. The limitations now clearly state that AD evidence should count as one well-supported domain rather than many independent positives.

### Major Concerns

1. The title remains too broad. "Trustworthy Agentic Neuroimaging Discovery" implies that the system produces trustworthy discoveries. The evidence supports trustworthy adjudication of proposed claims, not discovery quality.

2. The abstract still says verdicts are stable in a six-model probe. That is acceptable if kept as "small six-model probe", but risky if readers infer broad model robustness.

3. The external result is not a clean win. NACC has 9/9 positives but an external null-control CI upper bound above 10%; ds000030 has 0/14 positives. The manuscript should not let the combined 0/44 external null count distract from the failed psychiatric positive recovery.

4. The "to our knowledge" novelty claim around an early external frozen-configuration evaluation may be hard to defend without a citation audit. It is not necessarily wrong, but it is not established from local evidence alone.

5. The main novelty is systems integration, not new statistics. The manuscript mostly handles this now, but "two gates are new in this setting" should remain narrowly qualified.

### Technical Failings That Need To Be Addressed Before The Case Is Established

1. Retitle or subtitle to emphasize claim governance rather than discovery.

2. Recast the external evidence as "initial external evaluation with mixed transportability" rather than general external validation.

3. Clearly state that ds000030 does not recover psychiatric positives and that this limits external positive recall.

4. Ensure the conclusion does not revert to older numbers or preregistration claims.

5. Add a concise "what is new relative to prior agentic neuroimaging systems" table, limited to claims the manuscript can support.

### Assessment Against Nature-Style Criteria

Originality: Good as a governance system for agentic science. Less strong as a statistical-methods contribution.

Scientific importance: Field-important and potentially cross-domain, but not yet shown to have immediate and far-reaching implications.

Interdisciplinary readership: Better than before. The LLM-governance problem is broad; the current empirical evidence is still narrow.

Technical soundness: Improved but not stable until the current factual mismatches are corrected.

Readability for nonspecialists: Improved, especially through the benchmark map and the "faithfulness not capability" discussion.

### Recommendation Posture

The revised paper is moving toward a credible systems contribution, but the broad significance claim should be narrowed.

## Reviewer 3

### Overall Assessment

The paper is now much easier to understand. The benchmark map, the explicit stress-test language, and the discussion of governance as faithfulness make the argument more accessible. A nonspecialist can now follow the core idea: automated agents should not be allowed to turn weak statistics into confident scientific prose.

The main readability problem is no longer abstract complexity. It is inconsistency. Readers will be confused when one section reports 0/177 and another reports 1/177, or when the text says ds000030 is underpowered while the artifact says the power gate passed. These inconsistencies undermine trust more than jargon does.

### Who Would Be Interested In The Results, And Why

Readers interested in scientific reliability, AI agents, reproducibility, and automated data analysis would care. The work has a clear cross-domain lesson: tool-using LLMs still need explicit governance over what they are allowed to assert.

### Major Strengths

1. The abstract now includes important caveats instead of saving them for the limitations.

2. The method has a clearer example and stronger explanation of why the LLM may draft but not numerically report.

3. The benchmark map helps readers interpret the many denominators.

4. The discussion now gives the right conceptual slogan: governance as faithfulness, not capability.

5. The limitations are more honest about synthetic stress tests, AD correlation, fixed design choices, and external nulls.

### Major Concerns

1. The paper still has too many denominators for casual readers: 27, 29, 40, 55, 150, 177, 25, 9, 28, 16, and 44. The benchmark map helps, but the paper needs a short sentence each time a denominator changes.

2. The conclusion is currently dangerous because it reintroduces old numbers and a "preregistered external evaluation of real-world faithfulness" framing that the manifest itself rejects.

3. The ds000030 paragraph is too interpretive. It tries to present 0/14 positives as "correct outcome, not a failure." That may be true under a governance philosophy, but a reviewer will still read it as a failed external positive-recovery test. The paper should own that more directly.

4. The phrase "trustworthy discovery" still works against the paper's improved framing. It invites the reader to judge discovery performance, where the paper is weaker.

5. The appendix table is useful but cramped. It may be more valuable as a supplement with wider columns and explicit label-source fields.

### Technical Failings That Need To Be Addressed Before The Case Is Established

1. Harmonize all counts and confidence bounds across abstract, experiments, limitations, conclusion, manifest, and tables.

2. Rewrite the ds000030 narrative to match the artifact, or regenerate the artifact to match the narrative.

3. Replace "preregistered" phrasing with "hash-locked frozen-configuration" unless a formal preregistration exists.

4. Add a one-paragraph "how to read the evidence strata" guide before the experiments table.

5. Move some claim-level provenance to supplement rather than relying on a dense longtable alone.

### Assessment Against Nature-Style Criteria

Originality: Clearer than before. The enforceable claim-contract idea is the readable center of the paper.

Scientific importance: The importance is plausible but still mostly prospective. The paper shows a promising safety layer, not a field-level solution.

Interdisciplinary readership: Improved. The core problem is understandable to readers outside neuroimaging.

Technical soundness: Reader trust is currently limited by cross-document inconsistencies.

Readability for nonspecialists: Improved substantially, but the denominator burden and inconsistent claims still create friction.

### Recommendation Posture

The manuscript is much closer to a coherent submission, but it needs a final consistency and provenance pass before external review.

## Cross-Review Synthesis

### Consensus Strengths

1. The revised paper has a stronger and more defensible central frame: statistical claim governance for scientific agents.

2. The method section now fixes the most important power-gate conceptual vulnerability by rejecting observed-effect power.

3. The new benchmark map and ablation table directly address earlier reviewer concerns about denominator opacity and weak baselines.

4. The manifest is a serious improvement over the previous provenance state.

5. Reporting ds000030/CNP is important and improves credibility, even though the result is mixed.

### Consensus Technical Risks

1. The conclusion still contains obsolete stress-suite numbers.

2. The ds000030/CNP narrative is inconsistent with the artifact's power-gate fields.

3. The preregistration/frozen-configuration language is still not aligned across manuscript, prereg file, and manifest.

4. The external evidence remains initial and mixed, not broad field-level validation.

5. Claim-level label provenance remains incomplete.

### Where Emphasis Differs Across Reviewers

Reviewer 1 places greatest weight on technical consistency and artifact-grounded claims. From this view, the paper is not ready until the stress-suite and CNP contradictions are fixed.

Reviewer 2 places greatest weight on originality and significance. From this view, the paper is promising but still oversells discovery and external generality.

Reviewer 3 places greatest weight on interdisciplinary readability. From this view, the revision made the story much clearer, but inconsistency now poses the biggest readability and trust problem.

### Broad-Interest / Significance Readout

The paper is significantly more compelling than the prior version. It now has a plausible cross-domain message: scientific agents need enforceable statistical contracts and numeric authorization before they can report findings. That is likely to interest readers beyond neuroimaging.

The manuscript still does not establish a broad "trustworthy discovery" result. The supported claim is narrower and stronger: CONFIRM is a conservative governance layer that reduces false confirmations in internal/adversarial tests, improves a runnable agent's faithfulness on a shared set, succeeds on well-powered AD/MCI external positives, and abstains on a harder psychiatric external cohort.

### Most Important Issues To Resolve Before A Strong Nature-Style Case Is Established

1. Fix all stale numbers, especially the conclusion's 1/177 and 3.1% text.

2. Make ds000030 artifact and narrative agree.

3. Align all provenance language to "frozen-configuration with SHA-256 hashes, not formal preregistration" unless a real preregistration exists.

4. Reframe external evidence as mixed initial external evaluation, not general external validation.

5. Add claim-level label provenance for the main benchmark and external sets.

6. Consider changing the title to remove "discovery" or clearly subordinate it to "claim governance".

## Risk / Unsupported Claims

1. "One false confirmation across 177" is currently unsupported by the revised results and manifest.

2. "3.1% upper bound" is stale if the current result is 0/177 with upper bound 2.1%.

3. "ds000030 is underpowered" is not supported by the current CNP artifact unless the power calculation is changed or explained differently.

4. "The power and replication gates withhold the ds000030 claims" is inconsistent with the artifact; the artifact shows no underpowered claims and final labels of `fragile`.

5. "Preregistered external evaluation" is not supported by the current manifest, which explicitly says not to claim formal preregistration.

6. "External validation" should remain qualified as initial and mixed: NACC positive recovery is strong, NACC null controls are random-label/procedural, and CNP positive recovery is 0/14.

7. "Stable across six LLMs" should remain "stable in a small six-model/nine-claim probe."

8. "Trustworthy discovery" remains broader than the demonstrated governance result.

9. "Known null" should be used carefully for random-label controls; they are procedural nulls, not necessarily literature-null scientific claims.

10. "Combined external null FCR 0/44" should not distract from the failed ds000030 positive-recovery bar.

## Bottom Line

The fixes resolved many of the first-pass concerns. The manuscript is now much closer to a defensible paper about claim governance for agentic neuroimaging.

The remaining blockers are concrete and fixable: update stale conclusion numbers, make ds000030 artifact and narrative consistent, align all provenance wording with the manifest, and keep the external-validation claim mixed and modest. After those fixes, the paper's core case will be much more coherent.
